Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|November 26, 2019
Downregulation of lumican enhanced mitotic defects and aneuploidy in lung cancer cellsCheng-Ta Yang, Ping-Chih Hsu, Shu-Er ChowNeoplasia (New York, N.Y.)|August 15, 2024
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletionsJen-Fen Fu, Cheng-Lung Hsu, Ping-Chih HsuBiomedicines|July 27, 2022
Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) CellsPing-Chih Hsu, Jhy-Ming Li, Cheng-Ta YangCancers|May 30, 2020
The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)Ping-Chih Hsu, Cheng-Ta Yang, David M Jablons, et al.Biomedicines|December 15, 2018
The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic CancerPing-Chih Hsu, Cheng-Ta Yang, David M Jablons, et al.International Journal of Molecular Sciences|August 8, 2019
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)Ping-Chih Hsu, David M Jablons, Cheng-Ta Yang, et al.Chemmedchem|November 26, 2024
Design and Synthesis of Unsymmetric Benzils, Quinoxalines, and Evaluations of their Anticancer Activities against Human Non-Small Lung Cancer CellsPing-Chih Hsu, Yu-Hsin Hsu, Chuan-Hsin Chang, et al.Clinics and Practice|February 24, 2023
Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case ReportsPing-Chih Hsu, Tai-Di Chen, Tsung-Yu Tsai, et al.Journal of Cellular and Molecular Medicine|February 13, 2026
Flavones and Aminoflavones Increase the Cytotoxicity of NK Cells in Human Non-Small Cell Lung CancerPing-Chih Hsu, Chih-Cheng Chien, Yang-Je Cheng, et al.American Journal of Cancer Research|November 16, 2022
The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expressionJhy-Ming Li, Ping-Chih Hsu, Feng-Che Kuan, et al.Pageof 8